Efficacy of Oxygen Therapy Delivered by Systems Using Oxygen-Saving Valves in COPD Patients
NCT ID: NCT01180803
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2010-07-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxygen Therapy Remote Monitoring in COPD Patients.
NCT05473780
Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival
NCT00871962
Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT03890224
Oxygen Portable Concentrator During Exercises in Patients With COPD
NCT00875719
Effects of Inspiratory and Expiratory Pressure Training Methods in Patients With Chronic Obstructive Pulmonary Disease
NCT02326181
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxygen-saving valves
pulse oxygen supplementation devices
oxygen therapy delivered by systems using oxygen-saving valves
continuous oxygen supplementation
continuous oxygen
oxygen therapy delivered by continuous liquid oxygen devices
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulse oxygen supplementation devices
oxygen therapy delivered by systems using oxygen-saving valves
continuous oxygen
oxygen therapy delivered by continuous liquid oxygen devices
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give their written consent
Exclusion Criteria
* Patients with restrictive respiratory disease
* Patients with cardiac or neurologic disease contre-indicating the different evaluations
45 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DELRIEU Jacqueline
Clinical Project Manager
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fédération ANTADIR
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EVAL- CLIN A00690-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.